Cite
Bioassays for the Evaluation of Target Neutralization and Complement-Dependent Cytotoxicity (CDC) of Therapeutic Antibodies
MLA
Nohemí, Salinas-Jazmín, et al. “Bioassays for the Evaluation of Target Neutralization and Complement-Dependent Cytotoxicity (CDC) of Therapeutic Antibodies.” Methods in Molecular Biology (Clifton, N.J.), vol. 2313, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........b99d3d2eb8895a1214c648bdf14f7d89&authtype=sso&custid=ns315887.
APA
Nohemí, S.-J., Emilio, M.-R., & Marco Antonio, V.-V. (2021). Bioassays for the Evaluation of Target Neutralization and Complement-Dependent Cytotoxicity (CDC) of Therapeutic Antibodies. Methods in Molecular Biology (Clifton, N.J.), 2313.
Chicago
Nohemí, Salinas-Jazmín, Medina-Rivero Emilio, and Velasco-Velázquez Marco Antonio. 2021. “Bioassays for the Evaluation of Target Neutralization and Complement-Dependent Cytotoxicity (CDC) of Therapeutic Antibodies.” Methods in Molecular Biology (Clifton, N.J.) 2313 (September). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........b99d3d2eb8895a1214c648bdf14f7d89&authtype=sso&custid=ns315887.